Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

PHASE3CompletedINTERVENTIONAL

Enrollment

227

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Cataracts

Interventions

DRUG

Nepafenac 1mg/ml eye drops, suspension

One drop in the study eye 3 times daily for 23 days

DRUG

Ketorolac Trometamol 5 mg/ml eye drops, solution

One drop in the study eye 3 times daily for 23 days

OTHER

Nepafenac vehicle eye drops

One drop in the study eye 3 times daily for 23 days

Trial Locations (1)

Bordeaux, Bordeaux